AR008765A1 - Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del - Google Patents
Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto delInfo
- Publication number
- AR008765A1 AR008765A1 ARP970102432A ARP970102432A AR008765A1 AR 008765 A1 AR008765 A1 AR 008765A1 AR P970102432 A ARP970102432 A AR P970102432A AR P970102432 A ARP970102432 A AR P970102432A AR 008765 A1 AR008765 A1 AR 008765A1
- Authority
- AR
- Argentina
- Prior art keywords
- composite
- same
- peptide
- recombinant
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9611775.9A GB9611775D0 (en) | 1996-06-06 | 1996-06-06 | Novel compounds |
GBGB9618540.0A GB9618540D0 (en) | 1996-09-05 | 1996-09-05 | Novel compounds |
GBGB9703493.8A GB9703493D0 (en) | 1997-02-20 | 1997-02-20 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008765A1 true AR008765A1 (es) | 2000-02-23 |
Family
ID=27268305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970102432A AR008765A1 (es) | 1996-06-06 | 1997-06-04 | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0912609A2 (xx) |
JP (1) | JP2000512137A (xx) |
KR (1) | KR20000016402A (xx) |
CN (1) | CN1221426A (xx) |
AR (1) | AR008765A1 (xx) |
AU (1) | AU3337297A (xx) |
BR (1) | BR9709529A (xx) |
CA (1) | CA2257240A1 (xx) |
CZ (1) | CZ397898A3 (xx) |
IL (1) | IL127153A0 (xx) |
NO (1) | NO985683D0 (xx) |
NZ (1) | NZ332879A (xx) |
PL (1) | PL330361A1 (xx) |
TR (1) | TR199802534T2 (xx) |
WO (1) | WO1997046585A2 (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002521496A (ja) | 1998-07-28 | 2002-07-16 | フラームス・インテルウニフェルシタイル・インスティチュート・フォール・ビオテヒノロヒー | レプチン介在性遺伝子誘導 |
US7208572B2 (en) | 1998-08-21 | 2007-04-24 | Albany Medical College | Leptin-related peptides |
US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
AU782230B2 (en) | 1999-09-22 | 2005-07-14 | Serono Genetics Institute S.A. | Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
ATE300611T1 (de) | 2000-05-22 | 2005-08-15 | Vlaams Interuniv Inst Biotech | Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungen |
DK1444516T3 (da) | 2001-10-22 | 2010-11-15 | Amgen Inc | Anvendelse af leptin til behandling af lipoatrofi hos mennesker og fremgangsmåde til at bestemme en prædisposition for denne behandling |
CA2535021A1 (en) | 2003-09-08 | 2005-03-17 | Applied Research Systems Ars Holding N.V. | Use of insp035 to treat fibrotic disease |
BRPI0507594A (pt) | 2004-02-11 | 2007-07-03 | Amylin Pharmaceuticals Inc | polipetìdeos hìbridos com propriedades selecionáveis |
EP1812038A1 (en) | 2004-11-18 | 2007-08-01 | VIB vzw | Fibronectin iii domain as leptin receptor antagonists |
WO2007022123A2 (en) | 2005-08-11 | 2007-02-22 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties |
WO2006086769A2 (en) | 2005-02-11 | 2006-08-17 | Amylin Pharmaceuticals, Inc. | Gip analog and hybrid polypeptides with selectable properties |
US7629315B2 (en) | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
EP2330125A3 (en) | 2005-08-11 | 2012-12-12 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides with selectable properties |
ES2319048B1 (es) * | 2007-06-20 | 2010-02-10 | Universitat De Les Illes Balears | Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios. |
US8889622B2 (en) | 2007-07-25 | 2014-11-18 | Washington University | Methods of inhibiting seizure in a subject |
GB2451858A (en) * | 2007-08-15 | 2009-02-18 | Sergiy Konovchuk | Methods of reducing body fat and treating obesity |
KR20100093104A (ko) | 2007-12-05 | 2010-08-24 | 아스트라제네카 아베 | 항비만제로서의 피페라진 |
WO2009071668A2 (en) | 2007-12-05 | 2009-06-11 | Biovitrum Ab (Publ) | Piperazine derivatives and their use as leptin receptor modulators |
EP2313094A1 (en) * | 2008-06-04 | 2011-04-27 | AstraZeneca AB | New pyridine derivatives as leptin receptor modulator mimetics |
EP2313096A1 (en) * | 2008-06-04 | 2011-04-27 | AstraZeneca AB (Publ) | New compounds v |
JP2012523434A (ja) | 2009-04-10 | 2012-10-04 | アミリン・ファーマシューティカルズ,インコーポレイテッド | エストロゲン欠乏哺乳類のためのアミリンアゴニスト化合物 |
WO2011143280A2 (en) * | 2010-05-11 | 2011-11-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
BR122021020041B1 (pt) | 2010-09-28 | 2023-03-07 | Amylin Pharmaceuticals, Llc | Polipeptídeo quimérico, seu uso e composição que o compreende |
CN104829707B (zh) * | 2015-05-06 | 2017-12-19 | 广东省生物资源应用研究所 | 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用 |
CN110183530A (zh) * | 2019-06-21 | 2019-08-30 | 深圳市亚辉龙生物科技股份有限公司 | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
US5552523A (en) * | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
JPH11501297A (ja) * | 1995-01-31 | 1999-02-02 | イーライ・リリー・アンド・カンパニー | 抗肥満症タンパク質 |
WO1996023815A1 (en) * | 1995-01-31 | 1996-08-08 | Eli Lilly And Company | Ob gene product antibodies |
AU5539596A (en) * | 1995-04-06 | 1996-10-23 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-06-04 JP JP10500240A patent/JP2000512137A/ja active Pending
- 1997-06-04 WO PCT/EP1997/002968 patent/WO1997046585A2/en not_active Application Discontinuation
- 1997-06-04 KR KR1019980709976A patent/KR20000016402A/ko not_active Application Discontinuation
- 1997-06-04 PL PL97330361A patent/PL330361A1/xx unknown
- 1997-06-04 NZ NZ332879A patent/NZ332879A/xx not_active IP Right Cessation
- 1997-06-04 CZ CZ983978A patent/CZ397898A3/cs unknown
- 1997-06-04 AU AU33372/97A patent/AU3337297A/en not_active Abandoned
- 1997-06-04 TR TR1998/02534T patent/TR199802534T2/xx unknown
- 1997-06-04 EP EP97929156A patent/EP0912609A2/en not_active Withdrawn
- 1997-06-04 CN CN97195311A patent/CN1221426A/zh active Pending
- 1997-06-04 CA CA002257240A patent/CA2257240A1/en not_active Abandoned
- 1997-06-04 IL IL12715397A patent/IL127153A0/xx unknown
- 1997-06-04 BR BR9709529A patent/BR9709529A/pt not_active Application Discontinuation
- 1997-06-04 AR ARP970102432A patent/AR008765A1/es unknown
-
1998
- 1998-12-04 NO NO985683A patent/NO985683D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3337297A (en) | 1998-01-05 |
BR9709529A (pt) | 1999-08-10 |
CN1221426A (zh) | 1999-06-30 |
KR20000016402A (ko) | 2000-03-25 |
WO1997046585A3 (en) | 1998-04-23 |
NO985683L (no) | 1998-12-04 |
NZ332879A (en) | 2000-09-29 |
PL330361A1 (en) | 1999-05-10 |
IL127153A0 (en) | 1999-09-22 |
CA2257240A1 (en) | 1997-12-11 |
WO1997046585A2 (en) | 1997-12-11 |
EP0912609A2 (en) | 1999-05-06 |
TR199802534T2 (xx) | 1999-03-22 |
JP2000512137A (ja) | 2000-09-19 |
CZ397898A3 (cs) | 1999-04-14 |
NO985683D0 (no) | 1998-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR008765A1 (es) | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del | |
ATE556719T1 (de) | Impfstoff gegen menschliche influenza, der vier peptide aus influenza enthält | |
CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
CO4790174A1 (es) | Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen | |
DE69417252D1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
ES2187756T3 (es) | Uso de una composicion farmaceutica que comprende un peptido supresor del apetito. | |
CO5170453A1 (es) | Composiciones farmaceuticas que comprenden acido (-)(3-trihalometoxi) (4-halofenil) acetico y metformina | |
ES2052729T3 (es) | Un procedimiento para aplicar un revestimiento compuesto a un sustrato. | |
AR002024A1 (es) | Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas. | |
NO20061455L (no) | 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
PE117399A1 (es) | CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP | |
BR9807618A (pt) | Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa. | |
ES2061520T3 (es) | Expresion de un antigeno especifico de tumor por un virus vector recombinante y utilizacion de este para el tratamiento preventivo o curativo del tumor correspondiente. | |
AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
AR024742A1 (es) | DERIVADOS CICLOPEPTIDICOS QUE ACTUAN COMO INHIBIDORES DE LA INTEGRINA ALFA v BETA 6, LOS MEDICAMENTOS A BASE DE ESTOS COMPUESTOS, LAS COMPOSICIONESFARMACEUTICAS QUE CONTIENEN AL MENOS UNO DE ESTOS MEDICAMENTOS, Y EL EMPLEO DE ESTOS PEPTIDOS PARA PREPARAR UN MEDICAMENTO. | |
DK1014948T3 (da) | Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider | |
ID21353A (id) | Senyawa bi-aromatik yang terikat melalui radikal heteroetilena, serta komposisi farmasi dan kosmetik yang mengandungnya | |
DK527187D0 (da) | Gonadoliberin-analoge, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
CO5271650A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia | |
AR004497A1 (es) | Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica. | |
SE9700301D0 (sv) | New compound | |
ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. | |
BR0112141A (pt) | Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpo | |
ATE46173T1 (de) | Pharmakologisch aktive peptide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |